Publication date: Aug 24, 2026
Background: Handgrip strength has been proposed as an objective marker of post-COVID functional impairment, but its contribution relative to fatigue and sleep quality has not been formally evaluated in Latin American populations. Methods: We conducted an exploratory cross-sectional analysis of 130 adults with post-COVID condition in Palmira, Colombia. The outcome was any functional limitation on the Post-COVID Functional Status (PCFS) scale (grades 1-4 versus grade 0). Eight predictors were pre-specified on clinical grounds before examining outcome associations, and ridge-penalized logistic regression was pre-specified as the primary model. Sample size adequacy followed the criteria of Riley et al. Internal validation used bootstrap optimism correction (B = 1000), re-running the complete pipeline within each replicate. We assessed calibration, decision curves, prediction stability, SHapley Additive exPlanations (SHAP) with bootstrap rank intervals, and subgroup performance. Reporting followed TRIPOD + AI; risk of bias was self-assessed with PROBAST + AI. Results: Functional limitation affected 91/130 participants (70. 0%). The minimum sample required for eight parameters was 566; the cohort met 23. 0% of this requirement, so the analysis is exploratory. The optimism-corrected area under the curve was 0. 748 (95% confidence interval (CI) 0. 669-0. 830), with calibration slope 1. 15 (0. 71-1. 69). Fatigue ranked first in SHAP importance (54. 0% of resamples), whereas grip strength ranked fifth (median rank 6). Net benefit exceeded both default strategies between thresholds 0. 38 and 0. 88. Thirty percent of participants changed classification in over 20% of resamples. Conclusions: Fatigue, sleep quality and acute-phase severity, rather than grip strength, emerged as the most influential correlates. These hypothesis-generating findings require confirmation in adequately powered cohorts.
Open Access PDF
| Concepts | Keywords |
|---|---|
| algorithmic fairness | |
| exploratory analysis | |
| fatigue | |
| functional status | |
| handgrip strength | |
| machine learning | |
| post-COVID condition | |
| TRIPOD + AI |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Sarcopenia |
| disease | MESH | Fatigue |
| disease | MESH | post-COVID condition |
| drug | DRUGBANK | Methionine |
| disease | MESH | SARS CoV 2 infection |
| disease | MESH | Coinfection |
| disease | MESH | superinfection |
| drug | DRUGBANK | Flunarizine |
| disease | MESH | sleep disorders |
| disease | MESH | chronic obstructive pulmonary disease |
| disease | MESH | infection |
| disease | MESH | syndrome |
| disease | MESH | pain |
| disease | MESH | dizziness |
| disease | MESH | cognitive symptoms |
| disease | MESH | cap |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| drug | DRUGBANK | Vildagliptin |
| drug | DRUGBANK | Trestolone |
| disease | MESH | included |